Querying alternative splicing in the brain

Credit: Copyright Pasieka/Photo Researchers, Inc." /> Credit: Copyright Pasieka/Photo Researchers, Inc. Alternative splicing promises to help resolve the question of how 25,000 genes could possibly be enough to encode instructions for a huge range of specialized human cells from osteoplast to neuron. Robert Darnell and colleagues at The Rockefeller University, New York, combined microarray analysis with sophisticated bioinformatics too

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Alternative splicing promises to help resolve the question of how 25,000 genes could possibly be enough to encode instructions for a huge range of specialized human cells from osteoplast to neuron. Robert Darnell and colleagues at The Rockefeller University, New York, combined microarray analysis with sophisticated bioinformatics tools to identify, test, and validate 49 targets of the neuronal splicing factor, Nova, revealing that many of these proteins function in the synapse.1 Annette Dolphin, professor of pharmacology, University College London, calls the techniques employed by Darnell's team "absolutely amazing."

"It was pointed out to me by a postdoc that Darnell had found alternative splicing in a calcium channel. I was fascinated by his findings in general and the methods that he used to find these specific alternative splice variants that only occur in brain.

"First author Jernej Ule and colleagues really harnessed the power of bioinformatics, not just to make lists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies